Acutus Medical Balance Sheet Health
Financial Health criteria checks 0/6
Acutus Medical has a total shareholder equity of $-10.3M and total debt of $32.4M, which brings its debt-to-equity ratio to -314.1%. Its total assets and total liabilities are $32.2M and $42.5M respectively.
Key information
-314.1%
Debt to equity ratio
US$32.35m
Debt
Interest coverage ratio | n/a |
Cash | US$12.60m |
Equity | -US$10.30m |
Total liabilities | US$42.47m |
Total assets | US$32.17m |
Recent financial health updates
Recent updates
Investors Give Acutus Medical, Inc. (NASDAQ:AFIB) Shares A 29% Hiding
Feb 24Market Cool On Acutus Medical, Inc.'s (NASDAQ:AFIB) Revenues Pushing Shares 43% Lower
Dec 20Take Care Before Diving Into The Deep End On Acutus Medical, Inc. (NASDAQ:AFIB)
Jul 18Acutus files for FDA approval of catheter ablation system AcQBlate
Oct 18Acutus Medical Non-GAAP EPS of -$0.93 misses by $0.17, revenue of $4.1M beats by $0.13M
Aug 11Acutus Medical sees Q2 revenue above consensus estimate
Jul 21Acutus Medical, Inc. (NASDAQ:AFIB) Analysts Just Trimmed Their Revenue Forecasts By 25%
Apr 06Acutus Medical: A Name To Slowly Accumulate
Sep 04Acutus Medical, Inc.: Paradigm-Shifting Technology At A Shocking Price
Jul 21Acutus Medical cleared to start atrial fibrillation IDE trial
May 27Analysts Have Been Trimming Their Acutus Medical, Inc. (NASDAQ:AFIB) Price Target After Its Latest Report
May 15Financial Position Analysis
Short Term Liabilities: AFIB has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: AFIB has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: AFIB has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: AFIB's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AFIB has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AFIB has less than a year of cash runway if free cash flow continues to grow at historical rates of 4.3% each year.
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 08:44 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Acutus Medical, Inc. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Robert Hopkins | BofA Global Research |
Michael Gorman | BTIG |
William Plovanic | Canaccord Genuity |